Cargando…

Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence

Purpose of this study was to evaluate the diagnostic performance of T1 relaxation time (T1) for differentiating prostate cancer (PCa) from benign tissue as well as high- from low-grade PCa. Twenty-three patients with suspicion for PCa were included in this prospective study. 3 T MRI including a Modi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baur, Alexander D. J., Hansen, Carla M., Rogasch, Julian, Posch, Helena, Elezkurtaj, Sefer, Maxeiner, Andreas, Erb-Eigner, Katharina, Makowski, Marcus R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033189/
https://www.ncbi.nlm.nih.gov/pubmed/32080281
http://dx.doi.org/10.1038/s41598-020-59942-z
_version_ 1783499611067908096
author Baur, Alexander D. J.
Hansen, Carla M.
Rogasch, Julian
Posch, Helena
Elezkurtaj, Sefer
Maxeiner, Andreas
Erb-Eigner, Katharina
Makowski, Marcus R.
author_facet Baur, Alexander D. J.
Hansen, Carla M.
Rogasch, Julian
Posch, Helena
Elezkurtaj, Sefer
Maxeiner, Andreas
Erb-Eigner, Katharina
Makowski, Marcus R.
author_sort Baur, Alexander D. J.
collection PubMed
description Purpose of this study was to evaluate the diagnostic performance of T1 relaxation time (T1) for differentiating prostate cancer (PCa) from benign tissue as well as high- from low-grade PCa. Twenty-three patients with suspicion for PCa were included in this prospective study. 3 T MRI including a Modified Look-Locker inversion recovery sequence was acquired. Subsequent targeted and systematic prostate biopsy served as a reference standard. T1 and apparent diffusion coefficient (ADC) value in PCa and reference regions without malignancy as well as high- and low-grade PCa were compared using the Mann-Whitney U test. The performance of T1, ADC value, and a combination of both to differentiate PCa and reference regions was assessed by receiver operating characteristic (ROC) analysis. T1 and ADC value were lower in PCa compared to reference regions in the peripheral and transition zone (p < 0.001). ROC analysis revealed high AUCs for T1 (0.92; 95%-CI, 0.87–0.98) and ADC value (0.97; 95%-CI, 0.94 to 1.0) when differentiating PCa and reference regions. A combination of T1 and ADC value yielded an even higher AUC. The difference was statistically significant comparing it to the AUC for ADC value alone (p = 0.02). No significant differences were found between high- and low-grade PCa for T1 (p = 0.31) and ADC value (p = 0.8). T1 relaxation time differs significantly between PCa and benign prostate tissue with lower T1 in PCa. It could represent an imaging biomarker for PCa.
format Online
Article
Text
id pubmed-7033189
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70331892020-02-28 Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence Baur, Alexander D. J. Hansen, Carla M. Rogasch, Julian Posch, Helena Elezkurtaj, Sefer Maxeiner, Andreas Erb-Eigner, Katharina Makowski, Marcus R. Sci Rep Article Purpose of this study was to evaluate the diagnostic performance of T1 relaxation time (T1) for differentiating prostate cancer (PCa) from benign tissue as well as high- from low-grade PCa. Twenty-three patients with suspicion for PCa were included in this prospective study. 3 T MRI including a Modified Look-Locker inversion recovery sequence was acquired. Subsequent targeted and systematic prostate biopsy served as a reference standard. T1 and apparent diffusion coefficient (ADC) value in PCa and reference regions without malignancy as well as high- and low-grade PCa were compared using the Mann-Whitney U test. The performance of T1, ADC value, and a combination of both to differentiate PCa and reference regions was assessed by receiver operating characteristic (ROC) analysis. T1 and ADC value were lower in PCa compared to reference regions in the peripheral and transition zone (p < 0.001). ROC analysis revealed high AUCs for T1 (0.92; 95%-CI, 0.87–0.98) and ADC value (0.97; 95%-CI, 0.94 to 1.0) when differentiating PCa and reference regions. A combination of T1 and ADC value yielded an even higher AUC. The difference was statistically significant comparing it to the AUC for ADC value alone (p = 0.02). No significant differences were found between high- and low-grade PCa for T1 (p = 0.31) and ADC value (p = 0.8). T1 relaxation time differs significantly between PCa and benign prostate tissue with lower T1 in PCa. It could represent an imaging biomarker for PCa. Nature Publishing Group UK 2020-02-20 /pmc/articles/PMC7033189/ /pubmed/32080281 http://dx.doi.org/10.1038/s41598-020-59942-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Baur, Alexander D. J.
Hansen, Carla M.
Rogasch, Julian
Posch, Helena
Elezkurtaj, Sefer
Maxeiner, Andreas
Erb-Eigner, Katharina
Makowski, Marcus R.
Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence
title Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence
title_full Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence
title_fullStr Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence
title_full_unstemmed Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence
title_short Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence
title_sort evaluation of t1 relaxation time in prostate cancer and benign prostate tissue using a modified look-locker inversion recovery sequence
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033189/
https://www.ncbi.nlm.nih.gov/pubmed/32080281
http://dx.doi.org/10.1038/s41598-020-59942-z
work_keys_str_mv AT bauralexanderdj evaluationoft1relaxationtimeinprostatecancerandbenignprostatetissueusingamodifiedlooklockerinversionrecoverysequence
AT hansencarlam evaluationoft1relaxationtimeinprostatecancerandbenignprostatetissueusingamodifiedlooklockerinversionrecoverysequence
AT rogaschjulian evaluationoft1relaxationtimeinprostatecancerandbenignprostatetissueusingamodifiedlooklockerinversionrecoverysequence
AT poschhelena evaluationoft1relaxationtimeinprostatecancerandbenignprostatetissueusingamodifiedlooklockerinversionrecoverysequence
AT elezkurtajsefer evaluationoft1relaxationtimeinprostatecancerandbenignprostatetissueusingamodifiedlooklockerinversionrecoverysequence
AT maxeinerandreas evaluationoft1relaxationtimeinprostatecancerandbenignprostatetissueusingamodifiedlooklockerinversionrecoverysequence
AT erbeignerkatharina evaluationoft1relaxationtimeinprostatecancerandbenignprostatetissueusingamodifiedlooklockerinversionrecoverysequence
AT makowskimarcusr evaluationoft1relaxationtimeinprostatecancerandbenignprostatetissueusingamodifiedlooklockerinversionrecoverysequence